Excessive Biologic Response to IFNβ Is Associated with Poor Treatment Response in Patients with Multiple Sclerosis

BACKGROUND: Interferon-beta (IFNβ) is used to inhibit disease activity in multiple sclerosis (MS), but its mechanisms of action are incompletely understood, individual treatment response varies, and biological markers predicting response to treatment have yet to be identified. METHODS: The relations...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Rudick, Richard A., Rani, M. R. Sandhya, Xu, Yaomin, Lee, Jar-Chi, Na, Jie, Shrock, Jennifer, Josyula, Anupama, Fisher, Elizabeth, Ransohoff, Richard M.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Public Library of Science 2011
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3094352/
https://ncbi.nlm.nih.gov/pubmed/21602934
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0019262
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items